Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair shedding during Mounjaro treatment is real, it is common, and in most cases it does grow back. The shedding typically begins a few weeks after significant weight loss starts and is usually temporary, driven by physical stress on the body rather than by tirzepatide itself. Mounjaro is a prescription-only medicine requiring individual clinical assessment before it can be supplied. As with all side effects of Mounjaro, a prescriber is the right person to discuss what you're experiencing and whether any action is needed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The clinical name is telogen effluvium. When the body undergoes significant physiological stress, including rapid weight loss, more hair follicles than usual shift early into the resting (telogen) phase of the hair cycle. Around two to four months later, that resting hair falls out. The timing is why many people notice shedding after they are already well into treatment, it reflects what happened to the body weeks earlier, not a sudden new problem.
Tirzepatide, the active ingredient in Mounjaro, is a dual GIP and GLP-1 receptor agonist. The weight-loss effect is the likely driver of the shedding, not the molecule itself. The NHS medicines page for tirzepatide lists hair loss among the known side effects, and it featured in the SURMOUNT clinical trials, so this is not an obscure or poorly documented phenomenon. Thinking of it as a side effect of success, whilst frustrating, is a reasonable frame.
If you want a fuller picture of how this sits alongside other reported side effects, our Mounjaro hair loss overview covers the broader context in detail.
Two nutritional factors come up repeatedly in clinical practice: protein and iron. When appetite falls sharply on Mounjaro, people sometimes eat far less than their body needs to maintain muscle and support hair follicles. A protein intake that is genuinely adequate for your weight and activity level is not automatic on a very-low-appetite diet, it takes some deliberate planning.
Iron-deficiency anaemia is a separate but common contributor to hair loss in people who menstruate, and rapid weight loss can compound it. A simple blood test from your GP will show whether your levels are low. Zinc and biotin deficiencies are sometimes cited online, but the evidence for supplementation is thin unless a deficiency is confirmed.
Practically: prioritise protein at every meal, stay well hydrated, and consider asking your GP for a full blood count if the shedding feels pronounced. Our page on reducing Mounjaro side effects includes broader dietary tips that apply here too. Some people also find that gentle scalp massage and avoiding heat styling during the shed period makes the experience more manageable.
For most people, yes. Telogen effluvium is self-limiting. Once the triggering stress resolves (whether that means the body adapting to a new weight, appetite stabilising, or nutrition improving) the follicle cycle normalises. Regrowth typically begins within three to six months of the peak shed. It can take a full year for thickness to return to what feels normal, so patience is genuinely required here.
The shedding is rarely uniform across the scalp. People often notice it most when washing or brushing hair, and it can feel alarming when handfuls come away. That's a completely understandable reaction. What matters clinically is whether the pattern and rate are consistent with telogen effluvium or whether something else is going on. More detail on the hair-loss timeline and regrowth is on our hair loss after Mounjaro page.
If regrowth has not started after six months, or if you notice patchy loss, scalp inflammation, or a distinct change in the texture of new growth, that warrants a GP appointment. These patterns can indicate androgenetic alopecia or other conditions that happen to emerge or worsen during this period rather than being caused by weight-loss treatment.
Telogen effluvium is distressing but not medically urgent. Some symptoms alongside hair changes do need prompt attention. See a GP or contact our prescribers if you notice significant fatigue, breathlessness or pallor alongside shedding, these may point to anaemia needing treatment. If you develop any new or worsening symptoms on Mounjaro, it is worth discussing them before assuming they are expected.
Separately, if you experience severe or persistent abdominal pain that radiates to your back (with or without vomiting) seek urgent medical care. The MHRA's January 2026 Drug Safety Update on GLP-1 medicines highlighted acute pancreatitis as an infrequent but serious side effect requiring prompt assessment. Hair loss is not a sign of pancreatitis, but if you are wondering whether Mounjaro will make you sick more broadly, the two are sometimes reported together simply because people are paying close attention to their bodies during treatment.
Any suspected side effect from Mounjaro can be reported through the MHRA Yellow Card scheme, this helps build the UK evidence base for newer medicines. Our prescribers at nume discuss suitability, expected side effects and management as a standard part of the free consultation, so nothing is left for you to figure out alone after your plain-packaged pen arrives.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.